FHIR © HL7.org  |  FHIRsmith 4.0.1  |  Server Home  |  XIG Home  |  XIG Stats  | 

FHIR IG analytics

Packagehl7.fhir.uv.pharm-quality
Resource TypeComposition
IdComposition-composition-drug-pq-risk.json
FHIR VersionR5

Resources that use this resource

No resources found


Resources that this resource uses

No resources found


Narrative

Note: links and images are rebased to the (stated) source

Generated Narrative: Composition

Resource Composition "composition-drug-pq-risk"

Profile: Composition - Drug PQ

status: final

type: Product Note - Summary for Risk of Impurities ()

date: 2023-10-01

author: Organization/organization-drug-pq-ex1 "AAA Molybdenum Products, Inc."

title: 3.2.P.2.2.4 - Summary for Risk of Impurities


Source1

{
  "resourceType": "Composition",
  "id": "composition-drug-pq-risk",
  "meta": {
    "profile": [
      "http://hl7.org/fhir/uv/pharm-quality/StructureDefinition/Composition-drug-pq"
    ]
  },
  "text": {
    "status": "generated",
    "div": "<!-- snip (see above) -->"
  },
  "status": "final",
  "type": {
    "text": "Product Note - Summary for Risk of Impurities"
  },
  "subject": [
    {
      "reference": "MedicinalProductDefinition/medicinalproductdefinition-drug-product-pq-ex1"
    }
  ],
  "date": "2023-10-01",
  "author": [
    {
      "reference": "Organization/organization-drug-pq-ex1"
    }
  ],
  "title": "3.2.P.2.2.4 - Summary for Risk of Impurities",
  "section": [
    {
      "text": {
        "status": "additional",
        "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">\n                <p>Text for the risk assessment of elemental impurities in the product</p>\n            </div>"
      }
    }
  ]
}